Recent applications of hydantoin and thiohydantoin in medicinal chemistry
- PMID: 30622025
- DOI: 10.1016/j.ejmech.2018.12.066
Recent applications of hydantoin and thiohydantoin in medicinal chemistry
Abstract
Hydantoin, imidazolidine-2,4-dione, is a non-aromatic five-membered heterocycle, which is considered a valuable, privileged scaffold in medicinal chemistry. The importance of the hydantoin scaffold in drug discovery has been reinforced by several medicines in clinical use, such as phenytoin, nitrofurantoin, and enzalutamide. Hydantoin has five potential substituent sites, including two hydrogen bond acceptors and two hydrogen bond donors. Two additional attractive features of hydantoin scaffolds are their synthetic feasibility for core scaffolds via established cyclization reactions and their ease of accepting various substituents. Because of these characteristics, many hydantoin derivatives with different substituents have been designed and synthesized and exhibit a broad spectrum of biological and pharmacological activities against, for example, cancers, microbial infections, metabolic diseases, and epilepsy. In this review, recent contributions of hydantoin, thiohydantoin, and selenohydantoin scaffolds to medicinal chemistry are described; some major compounds are presented to emphasize their importance, and their structure-activity relationships (SARs) are briefly addressed. Major discussions are devoted to the structural features or novelty of each scaffold and its SAR. The publications in this review encompass those from 2012 to 2018.
Keywords: Heterocycle; Hydantoin; Imidazolidine-2,4-dione; Medicinal chemistry; Thiohydantoin.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Recent Development in Hydantoins, Thiohydantoins, and Selenohydantoins as Anticancer Agents: Structure-activity Relationship and Design Strategies.Mini Rev Med Chem. 2025;25(9):693-726. doi: 10.2174/0113895575329643241206101210. Mini Rev Med Chem. 2025. PMID: 39810539 Review.
-
Structural requirements for hydantoins and 2-thiohydantoins to induce lymphoproliferative popliteal lymph node reactions in the mouse.Int J Immunopharmacol. 1988;10(8):997-1010. doi: 10.1016/0192-0561(88)90047-1. Int J Immunopharmacol. 1988. PMID: 3215711
-
[Preliminary comparative pharmacological studies of 3-aryl and 3-alkyl-5-benzylidene derivatives of hydantoin, 2-thiohydantoin and 2-selenohydantoin].Acta Pol Pharm. 1983;40(4):517-22. Acta Pol Pharm. 1983. PMID: 6673512 Polish. No abstract available.
-
Solution-phase parallel annulation of (thio)hydantoins to tetrahydroisoquinolines and tetrahydro-beta-carbolines containing the 2-arylethyl amine scaffold.J Comb Chem. 2009 Jul-Aug;11(4):547-55. doi: 10.1021/cc8001926. J Comb Chem. 2009. PMID: 19472984
-
Medicinal chemistry of vicinal diaryl scaffold: A mini review.Eur J Med Chem. 2019 Jan 15;162:1-17. doi: 10.1016/j.ejmech.2018.10.054. Epub 2018 Oct 31. Eur J Med Chem. 2019. PMID: 30396033 Review.
Cited by
-
A Prospective Repurposing of Dantrolene as a Multitarget Agent for Alzheimer's Disease.Molecules. 2019 Nov 25;24(23):4298. doi: 10.3390/molecules24234298. Molecules. 2019. PMID: 31775359 Free PMC article.
-
[3+2]-Cycloaddition of Nitrile Imines to Parabanic Acid Derivatives-An Approach to Novel Spiroimidazolidinediones.Int J Mol Sci. 2023 Dec 19;25(1):18. doi: 10.3390/ijms25010018. Int J Mol Sci. 2023. PMID: 38203188 Free PMC article.
-
Synthesis, crystal structure and Hirshfeld surface of ethyl 2-[2-(methyl-sulfan-yl)-5-oxo-4,4-diphenyl-4,5-di-hydro-1H-imidazol-1-yl]acetate (thio-phenytoin derivative).Acta Crystallogr E Crystallogr Commun. 2024 Aug 9;80(Pt 9):926-930. doi: 10.1107/S2056989024007345. eCollection 2024 Sep 1. Acta Crystallogr E Crystallogr Commun. 2024. PMID: 39267872 Free PMC article.
-
Turn-Mimic Hydantoin-Based Loops Constructed by a Sequential Multicomponent Reaction.J Org Chem. 2023 Nov 17;88(22):15790-15804. doi: 10.1021/acs.joc.3c01861. Epub 2023 Nov 6. J Org Chem. 2023. PMID: 37932902 Free PMC article.
-
N-Alkylhydantoins as New Organogelators and Their Ability to Create Thixotropic Mixed Molecular Organogels.Gels. 2022 Oct 8;8(10):638. doi: 10.3390/gels8100638. Gels. 2022. PMID: 36286139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information
Miscellaneous